Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-κB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 1,920.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 2,289.00 |
Description | Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-κB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors. |
Source |
Molecular Weight | 240.26 |
Formula | C14H12N2O2 |
CAS No. | 100234-59-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Picrasidine I 100234-59-1 Immunology/Inflammation MAPK NF-Κb NF-κB ROS inhibitor inhibit